OncoLink en espanõl
Share
Types of Cancer > Bone Cancers > Osteosarcoma > News
January 2009
Surgical remission of osteosarcoma predicts survival
March 2008
Spectrum's Levoleucovorin approved by US FDA for treatment of osteosarcoma
February 2008
Chemotherapy plus muramyl tripeptide improves osteosarcoma survival
January 2007
Intensified chemotherapy does not improve osteosarcoma survival
October 2006
Osteosarcoma recurrence rare, and sometimes treatable
March 2006
Age and other factors influence osteosarcoma outcomes
January 2006
Zoledronic acid reduces osteosarcoma lung metastases in mice
December 2005
Survival after osteosarcoma recurrence still poor
November 2005
Repeat lung resections safe after metastatic spread of osteosarcoma
September 2005
Outlook poor in youngsters with severe osteosarcoma
Chemotherapy and stem cells combat osteosarcoma
June 2005
Strontium-89 and chemotherapy curb bone cancer pain
April 2005
Onyvax reports early success with osteosarcoma cancer vaccine
December 2003
Recurrent osteosarcoma carries poor prognosis
May 2003
RECQL4 mutations may explain predisposition to osteosarcoma in RTS
Return of ovarian function after osteosarcoma chemotherapy common
March 2003
Second-line chemo may not benefit those with operable relapsing osteosarcoma
February 2003
Radiation therapy controls local disease in patients with osteosarcoma of the extremities
November 2002
Enkephalin-expressing vector cuts bone cancer pain in mice
April 2002
Amifostine an effective cytoprotectant in children being treated for osteosarcoma
February 2002
High-grade osteosarcoma patients can often achieve long-term survival
Limb salvage does not jeopardize survival in patients with osteosarcoma
March 2001
Adjuvant chemo for osteosarcoma apparently does not increase survival
September 2000
New method of parosteal osteosarcoma resection spares nerves, soft tissue